| Comparative Study of Immunogenicity and Safety of Flu-ID Vaccine Versus Flu-IM Vaccine (NCT00554333) | Sanofi Pasteur, a Sanofi Company | 2007-10-01 |
| Immunogenicity of a Split, Cell-Based, Inactivated, Trivalent Influenza Vaccine in Healthy Adult Subjects (NCT00845429) | Sanofi | 2007-10-01 |
| Non-Inferiority of Various GSK Bio's Influenza Vaccine Presentations in Adults Aged 65 Years and Over (NCT00532298) | GlaxoSmithKline | 2007-09-20 |
| Immunogenicity, Safety, Reactogenicity, Efficacy, Effectiveness and Lot Consistency of FluBlok (NCT00539981) | Sanofi | 2007-09-15 |
| Immunogenicity Study of Antibody Persistence and Booster Effect of DTaP-HB PRP~T Combined Vaccine in Filipino Infants (NCT00514709) | Sanofi Pasteur, a Sanofi Company | 2007-09-01 |
| Safety and Immunogenicity Study of a Booster Vaccination With a Non-Adjuvanted H5N1 Influenza Vaccine (Follow Up to Study 810501) (NCT00530660) | Alachua Government Services, Inc. | 2007-09-01 |
| Single Group Study of the Safety of and Immune Response to a Bird Flu Vaccine (H7N3) in Healthy Adults (NCT00516035) | National Institute of Allergy and Infectious Diseases (NIAID) | 2007-09-01 |
| Phase IV Clinical Trial of an Influenza Split Vaccine Anflu (NCT00556062) | Sinovac Biotech Co., Ltd | 2007-09-01 |
| Intradermal Influenza Vaccine Study in Elders (NCT00504231) | PATH | 2007-09-01 |
| Study of Immune Response in Adults and Elderly Subjects Vaccinated With Inactivated Influenza Vaccines (NCT00776438) | Sanofi Pasteur, a Sanofi Company | 2007-09-01 |
| Safety and Reactogenicity of FluBlok and Comparison of Immunogenicity, Efficacy and Effectiveness Against TIV (NCT00539864) | Protein Sciences Corporation | 2007-09-01 |
| Comparative Study of Influenza Vaccines in Adults, FLUVACS-year 4 (NCT00538512) | University of Michigan | 2007-09-01 |
| Study Evaluating 13 Valent Pneumococcal Conjugate Vaccine With Trivalent Inactivated Influenza Vaccine (NCT00521586) | Pfizer | 2007-09-01 |
| Pandemic Influenza Plasmid DNA Vaccines (Needle) (NCT00709800) | Vical | 2007-08-01 |
| Pandemic Influenza Plasmid DNA Vaccines (Needle-Free) (NCT00694213) | Vical | 2007-08-01 |
| Safety and Immunogenicity of Influenza H9 Vaccine in Humans (NCT00814229) | University Hospitals, Leicester | 2007-08-01 |
| Evaluate Reactogenicity & Immunogenicity of an Influenza Pandemic Candidate Vaccine (GSK1562902A) in Primed Adults (NCT00506350) | GlaxoSmithKline | 2007-08-01 |
| Trial to Describe the Safety and Immunogenicity of Fluzone® (NCT00524940) | Sanofi Pasteur, a Sanofi Company | 2007-08-01 |
| Study to Evaluate the Safety and Immune Response of Two-Doses of Candidate Influenza Vaccine GSK 1557484A in Adults (NCT00510874) | GlaxoSmithKline | 2007-07-28 |
| Evaluate Safety & Immunogenicity of a Pandemic Influenza Vaccine (GSK1562902A) in Children (NCT00502593) | GlaxoSmithKline | 2007-07-23 |
| Safety and Immunogenicity Study of Two Doses of an Inactivated H5N1 Influenza Vaccine (Whole Virion, Vero Cell Derived) (NCT00517517) | Alachua Government Services, Inc. | 2007-07-01 |
| Immunogenicity of a Surface Antigen, Inactivated Influenza Vaccine Formulation 2007-2008 (NCT00518453) | Novartis Vaccines | 2007-07-01 |
| A Phase III, Open-Label, Single-Dose Study to Evaluate the Safety and Immunogenicity of Fluviral® Vaccine (NCT00505453) | GlaxoSmithKline | 2007-07-01 |
| Evaluation of Efficacy and Safety of Peramivir in Adults With Acute Serious or Potentially Life-threatening Influenza (NCT00453999) | BioCryst Pharmaceuticals | 2007-07-01 |
| Safety Study of Recombinant M2e Influenza-A Vaccine in Healthy Adults (NCT00819013) | Sanofi | 2007-07-01 |
| Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2007/2008) When Administered to NON Elderly AND Elderly Subjects (NCT00518726) | Novartis Vaccines | 2007-06-01 |
| Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2007/2008) When Administered to Elderly Subjects (NCT00522236) | Novartis Vaccines | 2007-06-01 |
| Single Group Study of the Safety of and Immune Response to a Bird Flu Virus Vaccine (H5N1) in Healthy Adults (NCT00488046) | National Institute of Allergy and Infectious Diseases (NIAID) | 2007-06-01 |
| Safety and Immunogenicity of 2 Formulations of an Intramuscular A/H5N1 Pandemic Influenza Vaccine in Children (NCT00491985) | Sanofi Pasteur, a Sanofi Company | 2007-06-01 |
| Immunogenicity and Reactogenicity of Fluarix™ (Influsplit SSW®) 2007/2008 in People 18 Years Old or Above (NCT00476307) | GlaxoSmithKline | 2007-06-01 |
| A Phase 2 Study of Immunogenicity, Safety and Tolerability of CSL412 in Elderly Participants (NCT00479648) | Seqirus | 2007-05-01 |
| Pilot Study of Genotypic Analysis (NCT00421837) | National Institute of Allergy and Infectious Diseases (NIAID) | 2007-05-01 |
| Phase 3 Immunogenicity and Safety Study of an Inactivated H5N1 Influenza Vaccine (Whole Virion, Vero Cell Derived) (NCT00462215) | Alachua Government Services, Inc. | 2007-04-01 |
| Safety, and Immunogenicity of Two Influenza Vaccines in Healthy Subjects 3 to 64 Years Old (NCT00464672) | Novartis | 2007-04-01 |
| Safety, Tolerability and Pharmacokinetic Study of Biota-CS-8958 (NCT00311714) | Biota Scientific Management Pty Ltd | 2007-04-01 |
| A Phase 1/2 Clinical Trial of an Alphavirus Replicon Vaccine for Influenza (NCT00440362) | AlphaVax, Inc. | 2007-04-01 |
| Assess Consistency of Immunogenicity of GlaxoSmithKline Biologicals' Pandemic Influenza Vaccine (GSK1562902A) in Adults (NCT00449670) | GlaxoSmithKline | 2007-03-24 |
| Interferon as a Mucosal Adjuvant for Influenza Vaccine Given Intranasally (NCT00436046) | National Institute of Allergy and Infectious Diseases (NIAID) | 2007-03-01 |
| Response of Older Adults to Influenza Vaccination With Regard to Cytomegalovirus (CMV) Status (NCT00442975) | Public Health England | 2007-03-01 |
| Safety & Immunogenicity of an Alternative Immunization Schedule of GSK Bio's Pandemic Influenza Vaccine (GSK1119711A) (NCT00430521) | GlaxoSmithKline | 2007-02-05 |
| Open-Label Study of H5 Vaccine in Participants of Protocol 04-077 (NCT00402649) | National Institute of Allergy and Infectious Diseases (NIAID) | 2007-02-01 |
| A Randomised Controlled Trial of Face Masks and Hand Hygiene in Reducing Influenza Transmission in Households (NCT00425893) | Centers for Disease Control and Prevention | 2007-02-01 |
| REDucing Influenza Among University Students, University of California at Berkeley (NCT00448773) | Centers for Disease Control and Prevention | 2007-02-01 |
| Clinical IGSP-CHOP Boston (NCT00428831) | National Institute of Allergy and Infectious Diseases (NIAID) | 2007-02-01 |
| Evaluation of the Efficacy and Safety of Peramivir in Subjects With Uncomplicated Acute Influenza. (NCT00419263) | BioCryst Pharmaceuticals | 2007-01-01 |
| A Study of Oseltamivir (Tamiflu) for the Seasonal Prophylaxis of Influenza in Immunocompromised Participants (NCT00412737) | Hoffmann-La Roche | 2007-01-01 |
| A Retrospective, Observational Registry of Participants With Avian Influenza Infection (NCT02743676) | Hoffmann-La Roche | 2007-01-01 |
| Oseltamivir Treatment for Children Less Than 24 Months of Age With Influenza (NCT00391768) | National Institute of Allergy and Infectious Diseases (NIAID) | 2007-01-01 |
| Immunogenicity, Safety and Tolerability of Two Doses of FLUAD-H5N1 Influenza Vaccine in Adult and Elderly Subjects (NCT00434733) | Novartis | 2007-01-01 |
| A Randomized, Controlled, Unblinded, Clinical Trial of the Acceptability and Efficacy of Non-Pharmaceutical Methods in Preventing Spread of Influenza Within the Family (NCT00410176) | Ministry of Health, Israel | 2007-01-01 |
| Safety and Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) (NCT00424086) | Alachua Government Services, Inc. | 2007-01-01 |
| Inactivated Influenza A/H5N1 Vaccine in Adult Subjects at Risk of Occupational Exposure to Live H5N1 Viruses (NCT00417560) | Centers for Disease Control and Prevention | 2007-01-01 |
| Pomegranate Products for Prevention of Common Cold (NCT00617318) | Texas Heart Institute | 2007-01-01 |
| Project to Investigate Ways to Reduce the Spread of Influenza in Schools and Households With Children (NCT00446628) | Kiren Mitruka | 2007-01-01 |
| A Study of Tamiflu (Oseltamivir) Treatment in Laboratory-Confirmed Influenza. (NCT00436124) | Hoffmann-La Roche | 2007-01-01 |
| China Case Control Avian Influenza (NCT00428753) | National Institute of Allergy and Infectious Diseases (NIAID) | 2007-01-01 |
| Prospective Study of AI H5N1 in China (NCT00428493) | National Institute of Allergy and Infectious Diseases (NIAID) | 2007-01-01 |
| A Study of Tamiflu (Oseltamivir) for Seasonal Prophylaxis of Influenza in Children. (NCT00412555) | Hoffmann-La Roche | 2006-12-01 |
| Evaluate Safety & Immunogenicity of a Pandemic Influenza Vaccine (GSK1562902A) in Adults Over 60 Years of Age (NCT00397215) | GlaxoSmithKline | 2006-11-17 |
| Study Comparing the Immune Response and Safety of Fluarix and Fluzone Influenza Vaccines in Children (NCT00383123) | GlaxoSmithKline | 2006-11-02 |
| Safety and Immunogenicity of Two Adjuvanted and One Non-adjuvanted H5N1 Influenza Vaccine in Adults (NCT00382187) | Novartis Vaccines | 2006-11-01 |
| Proteomic Profiling for Influenza (NCT00133588) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-11-01 |
| Inpatient Influenza Surveillance (NCT00419861) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-11-01 |
| Comparison of Nylon Flocked Swabs and Saline Aspirates for Detection Respiratory Viruses (NCT00613184) | Kern Medical Center | 2006-11-01 |
| Th1 Response to Influenza: Aging and Vaccine Efficacy (NCT00396305) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-11-01 |
| Safety and Immunogenicity of 2 Commercially Available Influenza Vaccines in Children (NCT00408395) | Novartis Vaccines | 2006-11-01 |
| Study to Evaluate the Immunogenicity and Safety of a Second Vaccination With the Adjuvanted Influenza Vaccine Candidate (NCT00385840) | GlaxoSmithKline | 2006-10-20 |
| Study to Evaluate Reactogenicity and Immunogenicity of Revaccination With Adjuvanted Influenza Vaccine in Elderly (NCT00386113) | GlaxoSmithKline | 2006-10-16 |
| Study on the Incidence of Influenza and Its Complications, in Subjects Aged 50 Years and Over Vaccinated With Fluarix™ (NCT00377611) | GlaxoSmithKline | 2006-10-05 |
| Study to Evaluate the Immunogenicity and Safety of 2 Formulations of GlaxoSmithKline (GSK) Biologicals' GSK1247446A Low Dose Influenza Vaccine Candidate (NCT00374842) | GlaxoSmithKline | 2006-10-03 |
| Study to Evaluate the Immunogenicity and the Safety of an Adjuvanted Influenza Vaccine Candidate (NCT00363077) | GlaxoSmithKline | 2006-10-02 |
| Dose-Escalating Trial Using Vero Cell-culture Derived H5N1 +/- Aluminum in Adults (NCT00382980) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-10-01 |
| Intervention Study of Face Mask and Hand Sanitizer to Reduce Influenza Transmission (NCT00490633) | University of Michigan | 2006-10-01 |
| Trial to Collect Safety Data and Sera for Immunogenicity Testing (NCT00389857) | Sanofi Pasteur, a Sanofi Company | 2006-10-01 |
| Immunogenicity and Safety of FluBlok Trivalent Recombinant Hemagglutinin Influenza Vaccine in Healthy Pediatrics (NCT00336453) | Protein Sciences Corporation | 2006-10-01 |
| Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2006/2007) When Administered to Subjects 18 Years of Age or Older (NCT00342940) | Novartis | 2006-10-01 |
| Proteomic Profiling for Influenza Vaccination - FluMist (NCT00385281) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-10-01 |
| Immunogenicity of High-dose Inactivated, Split-virion Influenza Vaccine Versus Standard Fluzone Vaccine in the Elderly (NCT00391053) | Sanofi Pasteur, a Sanofi Company | 2006-10-01 |
| Study to Evaluate Reactogenicity and Immunogenicity of Revaccination With Adjuvanted Influenza Vaccine in Elderly Adults (NCT00386698) | GlaxoSmithKline | 2006-10-01 |
| Study of Inactivated, Split-Virion Influenza Vaccine Compared With Standard Fluzone Vaccine in Infants and Children (NCT00391391) | Sanofi | 2006-10-01 |
| Needle-free Jet Injection of Reduced-dose, Intradermal, Influenza Vaccine in >= 6 to < 24-month-old Children (NCT00386542) | Pedro Moro | 2006-10-01 |
| Safety of and Immune Response to a Bird Flu Virus Vaccine (H9N2) in Healthy Adults (Study B) (NCT00380237) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-10-01 |
| Study of a Pandemic Influenza Vaccine in Elderly Participants (NCT00376402) | Seqirus | 2006-10-01 |
| Effect of the Consumption of a Fermented Milk on Common Infections in Shift-workers (NCT01033799) | Danone Global Research & Innovation Center | 2006-10-01 |
| Safety and Immunogenicity of Fluzone® Vaccine in Children Who Received 2 Doses of the 2005-2006 Fluzone Formulation. (NCT00390884) | Sanofi Pasteur, a Sanofi Company | 2006-10-01 |
| A Study of a Bivalent Influenza Peptide Conjugate Vaccine in Healthy Adults (NCT00851266) | Merck Sharp & Dohme LLC | 2006-10-01 |
| Phase IV Trial to Determine the Safety and Immunogenicity of the WHO Formulation of the 2006-2007 Fluzone® Vaccine (NCT00389532) | Sanofi Pasteur, a Sanofi Company | 2006-10-01 |
| Comparison of the Immunogenicity, Safety and Reactogenicity of FluBlok, To a Licensed Vaccine In Elderly Adults (NCT00395174) | Protein Sciences Corporation | 2006-10-01 |
| Influenza Vaccine Postpartum Questionnaire (NCT00401700) | Unity Health Toronto | 2006-10-01 |
| Demonstrate the Superiority of the Immune Response of Adjuvanted Influenza Vaccine Induced in an Adult Population (NCT00377585) | GlaxoSmithKline | 2006-09-22 |
| A Study to Demonstrate the Efficacy of GSK Biologicals' Influenza Vaccine in Adults (NCT00363870) | GlaxoSmithKline | 2006-09-01 |
| Lot-to-Lot Consistency Study of the Investigational, Inactivated, Split-Virion Influenza Vaccine in Adults (NCT00383539) | Sanofi Pasteur, a Sanofi Company | 2006-09-01 |
| Safety and Immunogenicity of FluLaval™ TR and Fluarix® (Influenza Vaccines) in Young and Older Adults (NCT00380211) | GlaxoSmithKline | 2006-09-01 |
| Efficacy of Sambucol in the Treatment of Influenza (NCT00375115) | Hadassah Medical Organization | 2006-09-01 |
| Study of Inactivated, Split-Virion Influenza Vaccine Compared With the Reference Vaccine Vaxigrip® in the Elderly (NCT00383526) | Sanofi Pasteur, a Sanofi Company | 2006-09-01 |
| Study of a Pandemic Influenza Vaccine in Children (NCT00370864) | Seqirus | 2006-09-01 |
| Development of Immune Globulin Treatment for Avian Flu (NCT00383071) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-08-01 |
| Study to Evaluate the Safety and Immunogenicity of Fluarix™ 2006/2007 in Adults Aged 18 Years or Above (NCT00345904) | GlaxoSmithKline | 2006-07-01 |
| Phase II Study of Pandemic Influenza Vaccine (NCT00320346) | Seqirus | 2006-07-01 |
| A Study of the Immunogenicity and Safety of the 2006-2007 Influenza Vaccine (NCT00343681) | Sanofi Pasteur, a Sanofi Company | 2006-07-01 |